Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region

• Main Authors: Bimbo Diaz, Alejandro, Chow, Jeremy, Fan, Kee Hoo, Kok, Wei Koh, Chin, Gary Keong Lee, Wee, Siong Teo, Venketasubramanian, Narayanaswamy, Chun, Chieh Wang, Mehta, Radhika
• Format: Article
• Language: English
• Published: Bioexcel Publishing 2023
• Online Access: http://psasir.upm.edu.my/id/eprint/107426/1/107426.pdf; http://psasir.upm.edu.my/id/eprint/107426/; https://www.drugsincontext.com/early-experiences-with-edoxaban-for-stroke-prevention-in-atrial-fibrillation-in-the-southeast-asia-region/

Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous thromboembolism. The clinical benefit of edoxaban for stroke prevention in Asian patients with NVAF has been demonstrated in clinic...